
Today marks an exciting new chapter as Catalyst Pharmaceuticals joins @AngeliniPharma as their newly formed Global Rare Disease Business Unit. By bringing together Catalyst's deep expertise in rare diseases with Angelini Pharma's global reach and capabilities, we are strengthening our shared dedication to advancing innovation and improving the lives of patients around the world. Our commitment remains the same: to serve patients, healthcare providers, caregivers, advocacy partners, the rare disease community, and our employees with the dedication and excellence they desire and have come to expect from Catalyst. We look forward to what's ahead as we continue building the future together. Learn more: angelinipharma.com/news-medi… #AngeliniPharma #BrainHealth #RareDisease














